Literature DB >> 12784277

Tetrabenazine in the treatment of severe pediatric chorea.

Anjan Chatterjee1, Steven J Frucht.   

Abstract

Tetrabenazine (TBZ) is widely used to treat adults with hyperkinetic movement disorders; however, published experience with the drug in pediatric patients is limited. We report on 5 children with severe chorea who were treated with TBZ. TBZ effectively controlled chorea in 4 patients, and despite the need for relatively high doses, it was well tolerated. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784277     DOI: 10.1002/mds.10427

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

Review 1.  Chorea and related disorders.

Authors:  R Bhidayasiri; D D Truong
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

2.  GNAO1-Associated Movement Disorder.

Authors:  Radhika Dhamija; Jonathan W Mink; Binit B Shah; Howard P Goodkin
Journal:  Mov Disord Clin Pract       Date:  2016-03-11

Review 3.  Tourette's syndrome and role of tetrabenazine: review and personal experience.

Authors:  Mauro Porta; Marco Sassi; Mario Cavallazzi; Maurizio Fornari; Arianna Brambilla; Domenico Servello
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 4.  Tetrabenazine: Spotlight on Drug Review.

Authors:  Navneet Kaur; Puneet Kumar; Sumit Jamwal; Rahul Deshmukh; Vinod Gauttam
Journal:  Ann Neurosci       Date:  2016-09-09

5.  Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature.

Authors:  Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.